We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lipemia Interferes with Routine Clinical Biochemical Tests

By LabMedica International staff writers
Posted on 18 Jul 2011
Print article
An abnormally high concentration of lipid in the blood may influence biochemical parameters in the clinical laboratory.

The effect of lipid removal using ultracentrifugation of lipemic samples has been examined in respect to some routine biochemistry parameters, such as bilirubin, glucose, gamma-glutamyl transferase (GGT) and aspartate aminotransferase (AST).

Scientists at the University Hospital Miguel Servet (Zaragoza, Spain) selected 110 samples taken from the daily input into their laboratory. All these specimens were visibly muddy and underwent a variety of biochemical tests before and after ultracentrifugation. The process by which samples were subjected to ultracentrifugation was at 40,000 × g and +4 °C, without adjustment of density (d = 1.006 kg/L) for 18 hours in a Centrikon T-1080 Ultracentrifuge, (Kontron AG; Zurich Switzerland). Ultracentrifugation can achieve greater speed of rotation than high-speed centrifugation, and therefore generate higher centrifugal forces.

The biochemical tests determined in the first aliquot and in the aliquot subjected to ultracentrifugation were the following: cholesterol, triglycerides, alkaline phosphatase (ALP), GGT, AST, alanine aminotransferase (ALT), lactate dehydrogenase (LD), total bilirubin, total calcium, creatinine, phosphorus, glucose, iron, urea, uric acid and total protein in a Hitachi Modular D and P analyzer, (Roche Diagnostics, Mannheim, Germany).

The investigators found significant differences in all the parameters studied except for total bilirubin, glucose, GGT, and AST. The greatest differences in the parameters analyzed were found in the concentration of ALT at 7.36% and the least differences for the concentration of glucose at 0.014%. Clinically significant interferences were found for phosphorus, creatinine, total protein, and calcium. The author's concluded that a major limitation of the study is that they used ultracentrifugation to reduce lipemia and many laboratories do not have ultracentrifuges, moreover this is a very long procedure for treatment of samples that come, in many occasions, from Emergency Services. The study was published in June 2011, in Biochemia Medica.

Related Links:
Kontron AG
Roche Diagnostics

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.